310 related articles for article (PubMed ID: 27120771)
1. Polyhydramnios, Transient Antenatal Bartter's Syndrome, and MAGED2 Mutations.
Laghmani K; Beck BB; Yang SS; Seaayfan E; Wenzel A; Reusch B; Vitzthum H; Priem D; Demaretz S; Bergmann K; Duin LK; Göbel H; Mache C; Thiele H; Bartram MP; Dombret C; Altmüller J; Nürnberg P; Benzing T; Levtchenko E; Seyberth HW; Klaus G; Yigit G; Lin SH; Timmer A; de Koning TJ; Scherjon SA; Schlingmann KP; Bertrand MJ; Rinschen MM; de Backer O; Konrad M; Kömhoff M
N Engl J Med; 2016 May; 374(19):1853-63. PubMed ID: 27120771
[TBL] [Abstract][Full Text] [Related]
2. MAGED2: a novel form of antenatal Bartter's syndrome.
Kömhoff M; Laghmani K
Curr Opin Nephrol Hypertens; 2018 Jul; 27(4):323-328. PubMed ID: 29677005
[TBL] [Abstract][Full Text] [Related]
3. A novel MAGED2 variant in a Chinese preterm newborn with transient antenatal Bartter's syndrome with 4 years follow-up.
Ma M; Zhang M; Zhou Y; Yao F; Wei M; Li Z; Qiu Z
BMC Nephrol; 2021 Dec; 22(1):408. PubMed ID: 34895150
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of antenatal Bartter's syndrome.
Kömhoff M; Laghmani K
Curr Opin Nephrol Hypertens; 2017 Sep; 26(5):419-425. PubMed ID: 28598867
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Novel
Legrand A; Treard C; Roncelin I; Dreux S; Bertholet-Thomas A; Broux F; Bruno D; Decramer S; Deschenes G; Djeddi D; Guigonis V; Jay N; Khalifeh T; Llanas B; Morin D; Morin G; Nobili F; Pietrement C; Ryckewaert A; Salomon R; Vrillon I; Blanchard A; Vargas-Poussou R
Clin J Am Soc Nephrol; 2018 Feb; 13(2):242-250. PubMed ID: 29146702
[TBL] [Abstract][Full Text] [Related]
6. Transient Antenatal Bartter's Syndrome: A Case Report.
Meyer M; Berrios M; Lo C
Front Pediatr; 2018; 6():51. PubMed ID: 29594084
[TBL] [Abstract][Full Text] [Related]
7. Transient antenatal Bartter's Syndrome and X-linked polyhydramnios: insights from the genetics of a rare condition.
Quigley R; Saland JM
Kidney Int; 2016 Oct; 90(4):721-3. PubMed ID: 27633862
[TBL] [Abstract][Full Text] [Related]
8. A Case Report and Literature Review of a Novel Mutation in the MAGED2 Gene of a Patient With Severe Transient Polyhydramnios.
Wu X; Huang L; Luo C; Liu Y; Niu J
Front Pediatr; 2021; 9():778814. PubMed ID: 34926352
[No Abstract] [Full Text] [Related]
9. [Genetic analysis of a pedigree affected with Bartter's syndrome].
Yang K; Huo X; Zhang Y; Zhang M; Gao Y; Wu D; Lou G; Qi N; Zhang B; Wang D
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Jul; 36(7):701-703. PubMed ID: 31302915
[TBL] [Abstract][Full Text] [Related]
10. Prenatal diagnosis of MAGED2 gene mutation causing transient antenatal Bartter syndrome.
Takemori S; Tanigaki S; Nozu K; Yoshihashi H; Uchiumi Y; Sakaguchi K; Tsushima K; Kitamura A; Kobayashi C; Matsuhima M; Tajima A; Nagano C; Kobayashi Y
Eur J Med Genet; 2021 Oct; 64(10):104308. PubMed ID: 34400373
[TBL] [Abstract][Full Text] [Related]
11. MAGE-D2 and the Regulation of Renal Salt Transporters.
Knoers NV; Bindels RJ
N Engl J Med; 2016 May; 374(19):1888-90. PubMed ID: 27168439
[No Abstract] [Full Text] [Related]
12. MAGED2 Is Required under Hypoxia for cAMP Signaling by Inhibiting MDM2-Dependent Endocytosis of G-Alpha-S.
Seaayfan E; Nasrah S; Quell L; Kleim M; Weber S; Meyer H; Laghmani K; Kömhoff M
Cells; 2022 Aug; 11(16):. PubMed ID: 36010623
[TBL] [Abstract][Full Text] [Related]
13. A Case of a Novel MAGED2 Mutation Resulting in Non-transient Bartter's Syndrome in an Adult Female.
Albaba I; Azher S; Mehta S; Faddoul G
Cureus; 2023 May; 15(5):e38681. PubMed ID: 37288186
[TBL] [Abstract][Full Text] [Related]
14. Successful antenatal treatment of MAGED2-related Bartter syndrome and review of treatment options and efficacy.
Walsh CJ; Micke K; Elfman H; Bock M; Harper T; Zaretsky M; Galan HL; Behrendt N; Putra M
Prenat Diagn; 2024 Feb; 44(2):172-179. PubMed ID: 38159268
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel intronic mutation of MAGED2 gene in a Chinese family with antenatal Bartter syndrome.
Yan X; Hu Y; Zhang X; Gao X; Zhao Y; Peng H; Ouyang L; Zhang C
BMC Med Genomics; 2024 Jan; 17(1):23. PubMed ID: 38238844
[TBL] [Abstract][Full Text] [Related]
16. A step towards precision medicine in management of severe transient polyhydramnios: MAGED2 variant.
Arthuis CJ; Nizon M; Kömhoff M; Beck BB; Riehmer V; Bihouée T; Bruel A; Benbrik N; Winer N; Isidor B
J Obstet Gynaecol; 2019 Apr; 39(3):395-397. PubMed ID: 29893154
[No Abstract] [Full Text] [Related]
17. Fetal polyuria and hydramnios associated with Bartter's syndrome.
Sieck UV; Ohlsson A
Obstet Gynecol; 1984 Mar; 63(3 Suppl):22S-24S. PubMed ID: 6366663
[TBL] [Abstract][Full Text] [Related]
18. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK.
Simon DB; Karet FE; Rodriguez-Soriano J; Hamdan JH; DiPietro A; Trachtman H; Sanjad SA; Lifton RP
Nat Genet; 1996 Oct; 14(2):152-6. PubMed ID: 8841184
[TBL] [Abstract][Full Text] [Related]
19. MAGED2 Depletion Promotes Stress-Induced Autophagy by Impairing the cAMP/PKA Pathway.
Nasrah S; Radi A; Daberkow JK; Hummler H; Weber S; Seaayfan E; Kömhoff M
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686237
[TBL] [Abstract][Full Text] [Related]
20. Clinical Findings and Genetic Analysis of Nine Mexican Families with Bartter Syndrome.
Hernández NEG; Pérez LIE; Aguilera D; Camargo-Muñiz MD; Espinosa CFC; Jaramillo MCR; Salvador C; González ZL; Hureaux M; Vargas-Poussou R
Arch Med Res; 2023 Sep; 54(6):102859. PubMed ID: 37516009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
